2025. A Randomized Controlled Trial Comparing Vonoprazan and Proton Pump Inhibitors for Symptom Relief and Mucosal Healing in Scleroderma-Associated GERD. Journal of Carcinogenesis. 24, 8s (Oct. 2025), 542–546. DOI:https://doi.org/10.64149/J.Carcinog.24.8s.542-546.